Methyl 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate, 98%, 1g

1-(Pyrazin-2-yl)cyclopropanecarboxylic acid, 95.0%, 500mg

2-Amino-n-(cyclohexylmethyl)-2-methylpropanamide, 95%, 100mg

4-(BOC-AMINOMETHYL)-CYCLOHEXYLAMINE, 95.0%, 1g

3-(Benzyloxy)isoxazole-5-carbaldehyde, 98+%, 100mg

4-Bromo-2-(2-fluoroethoxy)pyridine, 98%, 500mg

4-Hydroxy-2-methylphenylboronic Acid (contains varying amounts of Anhydride)5g

Methyl 6-formylnicotinate, 95.0%, 250mg

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

N-(3-(7-(1,3-dimethyl-1H-pyrazol-5-ylamino)-1-methyl-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide, 98%, 10mg

Sample vials ROTILABO®, Clear glass, 15 ml, 100 Piece(s)

4-Fluorophenyl Acetate>98.0%(GC)5g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide, 95.0%, 100mg